KLK3 and prostate cancer: Following the recommendations of the AAFP, the NCI, the CDC, the ACS, the AUA, the NCCN, and ASCO, clinicians would find it less difficult to discuss PSA testing with patient D since he is an African American male with a first-degree relative diagnosed with prostate cancer before 65 years of age.